Welcome to our dedicated page for Blend Labs SEC filings (Ticker: BLND), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Blend Labs, Inc. (NYSE: BLND) files reports with the U.S. Securities and Exchange Commission as a Delaware corporation in the software publishers industry. On this BLND SEC filings page, Stock Titan aggregates the company’s regulatory disclosures, including current reports on Form 8-K and other periodic filings, and applies AI-powered summaries to help explain their contents in plain language.
Blend’s 8-K filings illustrate the types of material events the company reports to regulators and investors. Recent examples include the announcement of quarterly financial results, where Blend discusses software platform and professional services revenue, GAAP and non-GAAP gross margins, operating income or loss, and key operating metrics. Other 8-K filings cover leadership and executive transitions, such as changes in the Head of Finance and Administration role and related transition agreements, as well as appointments like the Head of Revenue.
Investors can also use this page to locate references to non-GAAP financial measures and the adjustments Blend applies, including stock-based compensation, workforce reduction costs, facilities-related charges, compensation realignment, litigation contingencies, transaction-related costs, software amortization and impairment, executive transition costs, and other items. These details are important for understanding how the company presents measures such as non-GAAP operating income and operating margin alongside GAAP results.
Stock Titan’s interface is designed to make it easier to work through Blend’s SEC disclosures. Users can quickly access quarterly and annual reports when available, review 8-K filings about results of operations, and see filings related to corporate governance or compensation matters. AI-generated highlights help surface the main points of each filing, including financial performance, key agreements, and leadership changes, so readers can navigate Blend’s regulatory history more efficiently.
Form 4 Overview: Blend Labs, Inc. (BLND) filed a Form 4 disclosing that Brian Kneafsey, the company’s Head of Revenue, sold 20,000 shares of Class A common stock on 23 June 2025.
Transaction specifics: The disposition was coded “S” (open-market sale) and executed at a weighted-average price of $3.1657 per share, within a range of $3.12–$3.205. Following the sale, Kneafsey still beneficially owns 806,598 shares, indicating the transaction reduced his direct holdings by roughly 2.5%.
Rule 10b5-1 plan: The insider noted that the trade was carried out under a Rule 10b5-1 trading plan adopted on 14 March 2025. Pre-arranged plans can mitigate concerns about informational advantage because trades are scheduled in advance.
Ownership context: Kneafsey is classified as an Officer – Head of Revenue; no director or 10% ownership status was indicated. The filing is made by a single reporting person, and there are no derivative security transactions reported.
Investor takeaways: While any insider sale can draw attention, the size of this sale is modest relative to the insider’s remaining stake, and its execution under a 10b5-1 plan lessens potential negative signalling. No information about Blend Labs’ operational performance, earnings, or other corporate events is provided in this filing.
Form 144 Notice of Proposed Sale filed by Blend Labs (NYSE: BLND) on June 28, 2025, detailing insider trading activity. The filing indicates a proposed sale of 20,000 shares of common stock with an aggregate market value of $63,315 through Charles Schwab & Co.
Key transaction details:
- Securities were originally acquired on February 17, 2020, through an Exercise and Hold transaction
- Sale represents a small portion of total outstanding shares (254,775,978 shares)
- Planned execution date: June 23, 2025
- Previous insider activity: The seller (Brian Kneafsey) sold 45,000 shares on June 16, 2025, for gross proceeds of $145,268
The seller affirms no knowledge of undisclosed material adverse information regarding Blend Labs' operations. This Form 144 represents a declaration of intent to sell securities acquired through stock options, indicating potential insider sentiment.